When do common medicines become dangerous or inefficient?

Authors

DOI:

https://doi.org/10.52556/2587-3873.2022.1(92).10

Keywords:

drug, pharmacotherapy, rational use, polypragmasia, polytherapy, pharmacovigilance

Abstract

Irrational prescriptions and ineffective use of drugs cause harm to the patient’s health, increase the financial costs of both the patient and the medical institution to remove the consequences of incorrect treatment, contribute to the occurrence of „drug disease”, unnecessarily burden the cost of treatment, increase the resistance of microorganisms ( due to irrational antibiotic therapy) and the lethality of patients due to serious infectious diseases usually lead to an increase in the frequency of side effects and complications of drug treatment. Realizing that harmless drugs do not exist, important and logical in rational pharmacotherapy, quite desirable, but also without unpleasant consequences, would be to know and inform with the most important moments, appeared in the process of using drugs, with the possible measures to prevent (avoid) them by answering the question „When do ordinary drugs become dangerous or do not work?”. Knowledge of the basic mechanisms of drug interactions, evidence of risk factors in performing pharmacotherapy, and a clearly arranged system of information on important clinical behaviors of drugs in various situations contribute to increasing the efficacy and harmless pharmacotherapeutic effect.

References

1. Barone Gary W., Gurley Bill J. et al. Herbal Supplements: a potential for drug interactions in transplant recipients. In: Clinical transplantology. 2001, vol. 71, issue 2, pp. 239-241. https://doi.org/10.1097/00007890-200101270-00012

2. Brunton L., Lazo J., Parket K. The Pharmacological Basis of Therapeutics. Goodman &Gilman's, 11th Edition, International McGraw-Hill. New York, 2006, 2021 p.

3. Lucas C,, Martin J. Smoking and drug interactions. Aust Presct, 2013, pp. 36, 3, 102-104. https://doi.org/10.18773/austprescr.2013.037

4. Cristea A.N.. Tratat de Farmacologie. Bucureşti, 2005, 1332 p.

5. Fugh-Berman A. Herb-drug interactions. In: Lancet, 2000, nr. 355, pp. 1019-1020. https://doi.org/10.1016/S0140-6736(05)74767-X

6. Fulga I. Farmacologie, ediţia a II -a revizuită şi adăugată, Bucureşti: Editura Medicală, 2017, 828 p.

7. Gorban G., Florescu N. Suplimente alimentare. Ghid, ediţia I-a, Bucureşti, 2013.

8. Gail D. Anderson. Lingtak-Neander Chan, Pharmacokinetic Drug interactions with Tabacco Cannabinoids and Smoking Cessation Products. Clin Pharmacokinet. 2016, Disponibil pe: https://doi.org/10.1007/s40262-016-0400-9

9. Gardiner P. et al. Factors associated with dietary supplement use among prescription medication users. In: Arch. Intern Med. 2006, nr. 166(18), pp. 1968-1974. https://doi.org/10.1001/archinte.166.18.1968

10. Ghicavîi V. Medicamentul: beneficiu sau prejudiciu, Chișinău: Tipografia Centrală, 2009, 455 p.

11. Ghicavîi V., Bacinschi N., Guşuilă Gh., Farmacologie. Ed. a III-a (revizuită şi competată). Chişinău, 2019, 1000 p.

12. Ghicavîi V., Guşuilă Gh. Compediu privind selectarea raţională a medicamentelor. Farmacologie. Chişinău, 1999, 28 p.

13. Ghicavîi V., Pogonea I., Corețchi I., Podgurschi L. Farmacoterapia modernă a dereglărilor digestive. Chișinău, 2017, 355 p.

Published

2026-04-20

Issue

Section

Articles

How to Cite

[1]
Ghicavai, V. et al. 2026. When do common medicines become dangerous or inefficient?. Public Health Economy and Management in Medicine. 1(92) (Apr. 2026), 61–74. DOI:https://doi.org/10.52556/2587-3873.2022.1(92).10.

Similar Articles

1-10 of 28

You may also start an advanced similarity search for this article.